- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1942
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Signaling COVID-19 Vaccine Adverse Events ; volume:45 ; number:7 ; day:23 ; month:6 ; year:2022 ; pages:765-780 ; date:7.2022
Drug safety ; 45, Heft 7 (23.6.2022), 765-780, 7.2022
- Urheber
-
Harpaz, Rave
DuMouchel, William
Manen, Robbert Van
Nip, Alexander
Bright, Steve
Szarfman, Ana
Tonning, Joseph
Lerch, Magnus
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40264-022-01186-z
- URN
-
urn:nbn:de:101:1-2022100122373472939955
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Harpaz, Rave
- DuMouchel, William
- Manen, Robbert Van
- Nip, Alexander
- Bright, Steve
- Szarfman, Ana
- Tonning, Joseph
- Lerch, Magnus
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
A statistical analysis of vaccine-adverse event data
COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia
Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
A statistical analysis of vaccine-adverse event data
COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia
Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
A statistical analysis of vaccine-adverse event data
COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia
Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine